Advertisement Feature |

Wenzhou Medical University: Sixty years of medical progresses

Wenzhou Medical University (WMU), located in eastern China’s Zhejiang province, is a provincial key university. In the 60 years since it established itself in Wenzhou, it has made great advances in talent training, building research capacity, and medical services. WMU particularly stands out for its pioneering ophthalmology and optometry programme which has a global reputation. Breakthroughs in novel therapeutics based on fibroblast growth factors by WMU pharmaceutical scientists are also making an impact. Its history of talented medical professionals and rich healthcare resources speaks of its commitment to serving people in Zhejiang and beyond.

This advertisement feature is produced by the Partnership & Custom Media unit of Nature Research for Wenzhou Medical University. The advertiser retains responsibility for content. About this content.

Articles

  • Advertisement Feature

    In the 60 years since it was established, Wenzhou Medical University (WMU), located in eastern China’s Zhejiang province, has made great advances in talent training, research capacity building and medical services.

  • Advertisement Feature

    The School of Ophthalmology and Optometry at Wenzhou Medical University (WMU) has great vision in its field. Among its breakthroughs is the first proof that scleral hypoxia — a lack of oxygen in the white of the eye — can cause myopia. Their hypothesis has led to new treatments.

  • Advertisement Feature

    Growth factors (GFs) constitute a large and versatile family of signalling proteins that govern cell growth, division and survival, and therefore have great potential as therapeutics. At Wenzhou Medical University (WMU), researchers in the School of Pharmaceutical Sciences are spearheading basic GF research, and the development of novel biological drugs.

  • Advertisement Feature

    Severe acute pancreatitis can be lethal and has grave potential to cause complications, harming other vital organs. At the First Affiliated Hospital of Wenzhou Medical University (WMU), clinical faculty members have developed a comprehensive treatment system that reduces the mortality rate of this dangerous disease from 14.4% to 4.6%.

  • Advertisement Feature

    The Second Affiliated Hospital of Wenzhou Medical University (WMU) is leading a digital revolution for patient access. It is among China’s first to pilot the ‘cloud hospital’ platform, which lets patients make appointments, renew prescriptions, apply for admission, among other services, all from home. Its uptake of mobile and paperless healthcare has seen it collect the highest daily settlement amount of RMB 2.1 million ($305,659) on Alipay, China’s popular online payment platform, which tops Chinese hospitals and is indicative of patient preference of such streamlined processes.